Annual Newsletter 2017

Download a copy here. Newsletter_Autumn_2017.pdf

Latest

The Linked Clinical Trials Meeting 2019

The 2019 international Linked Clinical Trials meeting is being held this week in Grand Rapids, Michigan - this annual event is an important date in our calendar and heralds the process by which we are bringing much needed novel therapies for the Parkinson's into clinical trial as quickly as possible...
The BRAIN Tapping Test Goes Mobile

Researchers at UCL have recently published a study validating a mobile device test which could continually monitor individuals with Parkinson's...
Bayer Buys Blue Rock

Bayer pharmaceutical has bought BlueRock Therapeutics which could have some important implications for the Parkinson's community...
CPT Welcomes New Director of Fundraising & Marketing

The Cure Parkinson's Trust is delighted to announce Rick Lay in a new role as Director of Fundraising and Marketing.

The Linked Clinical Trials Meeting 2019

The 2019 international Linked Clinical Trials meeting is being held this week in Grand Rapids, Michigan - this annual event is an important date in our calendar and heralds the process by which we are bringing much needed novel therapies for the Parkinson's into clinical trial as quickly as possible...
The BRAIN Tapping Test Goes Mobile

Researchers at UCL have recently published a study validating a mobile device test which could continually monitor individuals with Parkinson's...
Bayer Buys Blue Rock

Bayer pharmaceutical has bought BlueRock Therapeutics which could have some important implications for the Parkinson's community...
CPT Welcomes New Director of Fundraising & Marketing

The Cure Parkinson's Trust is delighted to announce Rick Lay in a new role as Director of Fundraising and Marketing.
Tracking and Monitoring Parkinson's Symptoms at Home

People with Parkinson’s could see their care transformed thanks to the development of a new service involving wearable technology...
Over Reacting to an Absence of PINK

Two genes when mutated, PINK1 and PARKIN, are associated with young onset Parkinson's. Exactly why they increase the risk of developing Parkinson's has long been a mystery, but now Canadian scientists have published research that might be able to explain this increased susceptibility...
From Dreams to Parkinson's

Professor Michele Hu has published an interesting article providing an overview of the 'prodromal phase' or the period before diagnosis in Parkinson's...
The Appendix and Parkinson's

Although its exact role isn’t yet clear because findings have been conflicting, in this easy-to-read overview the link between the appendix and risk of developing Parkinson's is discussed...
The Rationale for the TRANSEURO Study

The TRANSEURO study is being funded by The Cure Parkinson's Trust and is investigating cell transplantation as a restorative therapy for people with Parkinson's. In this article, Prof Roger Barker explains the rational behind the trial design...
Not Easy for EGCG

Disappointing results for Epigallocatechin-gallate (EGCG) as study fails to show evidence of modifying disease progression in patients with Multiple System Atrophy.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
The Grouse & Grape Luncheon

The Grouse and Grape Luncheon will return to Spencer House on the 8th October 2019 where over 300 guests will be welcomed to take part in this flourishing networking event, all in the aid of The Cure Parkinson's Trust.

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more

Parkinson's Movement

The Science of Parkinson's - Dr Simon Stott

Leave a Legacy

A donation to The Cure Parkinson's Trust (CPT) will make a huge difference to our research to slow, stop or even reverse Parkinson's. Read more